desipramine has been researched along with Marasmus in 2 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vigliecca, NS | 1 |
| Molina, SC | 1 |
| Peñalva, MC | 1 |
| Molina, VA | 1 |
| Keller, EA | 1 |
| Orsingher, OA | 1 |
2 other studies available for desipramine and Marasmus
| Article | Year |
|---|---|
[Multivariate study of the Open Field Drink Test using undernourished rats and desipramine as an antipanic drug].
Topics: Animals; Anti-Anxiety Agents; Conflict, Psychological; Desipramine; Dietary Proteins; Drinking Behav | 2007 |
Reduced anti-immobility effect of repeated desipramine (DMI) treatment in adult rats undernourished at perinatal age.
Topics: Animals; Depression; Desipramine; Disease Models, Animal; Drug Administration Schedule; Female; Male | 1987 |